Market Tracker

11/26 4:45am ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

114.19
Data as of Nov 25
 +0.39 / +0.34%
Today’s Change
59.79
Today|||52-Week Range
118.17
+53.69%
Year-to-Date

Today’s Trading

Previous close113.80
Today’s open114.17
Day’s range-- - --
Volume1,786,132
Average volume (3 months)1,674,128
Market cap$27.4B
Dividend yield--
Data as of 11/25/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-50.30%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book19.61

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.67-1.50%
PRGOPerrigo Company PLC-0.42-0.27%
MYLMylan Inc+0.21+0.38%
ALXNAlexion Pharmaceutic...-1.38-0.71%
Data as of 11/25/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts